For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Dispatches
Tuesday 5 November 2024, 05:36 AM

Hato Hone St John is to receive $21 million in additional funding [Image: Hato Hone St John]
Keeping it brief – round up of news for the last month
$21-million boost to St John funding, Hato Hone St John will receive $21 million in additional government funding, boosting its government contribution to nearly $357 million for the finan
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.